Disclosure Of Interests In Other Entities [Text Block]

Sopharma AD - Filing #6175083

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Subsidiaries
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests
5 212 BGN
2 207 BGN
Non-controlling interests
11 976 BGN
11 893 BGN
Current assets
572 491 BGN
571 232 BGN
Non-current assets
681 487 BGN
633 746 BGN
Current liabilities
407 346 BGN
423 892 BGN
Non-current liabilities
129 998 BGN
122 218 BGN
Revenue
1 663 016 BGN
1 603 310 BGN
Profit (loss)
71 121 BGN
76 333 BGN
71 121 BGN
5 212 BGN
2 207 BGN
89 496 BGN
91 703 BGN
89 496 BGN
Comprehensive income
65 110 BGN
892,000 BGN
70 465 BGN
1 047 BGN
72 476 BGN
5 355 BGN
5 427 BGN
1 728 BGN
355,000 BGN
3 367 BGN
9 485 BGN
101 970 BGN
103 698 BGN
89 473 BGN
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Associates
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
6 011 BGN
892,000 BGN
5 868 BGN
1 047 BGN
1 355 BGN
143,000 BGN
5 427 BGN
479,000 BGN
355,000 BGN
3 367 BGN
9 485 BGN
12 474 BGN
11 995 BGN
23,000 BGN
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
19 855 BGN
37 722 BGN
Depreciation and amortisation expense
52 099 BGN
53 187 BGN
Tax expense (income)
8 743 BGN
5 871 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.